WHO Advisory Committee on Safety of Medicinal Products COVID-19 Therapeutics Sub-Committee

Overview

This document describes the terms of reference for a sub-committee of experts to be established under the aegis of ACSoMP for the purpose of reviewing, evaluating, and interpreting post-introduction safety data with new COVID-19 medicinal products in countries